BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38256341)

  • 1. Fractional CO
    Campos MLP; Bianchi-Ferraro AMHM; de Oliveira CD; Nogueira MCC; Sartori MGF; Fusco I; Lugollo AF; De Góis Speck NM
    Medicina (Kaunas); 2023 Dec; 60(1):. PubMed ID: 38256341
    [No Abstract]   [Full Text] [Related]  

  • 2. Women with Genitourinary Syndrome of Menopause Treated with Vaginal Estriol, Microablative Fractional CO
    de Oliveira CD; de Mello Bianchi AMH; Campos MLP; Nogueira MCC; Sartori MGF; de Góis Speck NM
    Photobiomodul Photomed Laser Surg; 2023 Dec; 41(12):718-724. PubMed ID: 38085184
    [No Abstract]   [Full Text] [Related]  

  • 3. Fractional and Microablative CO
    Caceres Nogueira MC; Homem de Mello Bianchi-Ferraro AM; Leonor Pereira Campos M; Dias Oliveira C; Gracio Ferreira Sartori M; Di Bella ZIKJ; Logullo AF; ; Speck NMG
    Photobiomodul Photomed Laser Surg; 2024 Jun; 42(6):414-421. PubMed ID: 38888192
    [No Abstract]   [Full Text] [Related]  

  • 4. Fractional Microablative CO
    Pagano T; Travaglino A; Raffone A; Vallone R; Buonfantino C; De Rosa P; Locci M; Guadagno E; Insabato L; Salvatore S; De Placido G
    Lasers Surg Med; 2021 Apr; 53(4):521-527. PubMed ID: 32797701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Fractional CO
    Li J; Li H; Zhou Y; Xie M; Miao Y; Wang L; Zhao Y; Ying T; Hu Y; Chen Y; Chen Y; Sun X; Wang J
    Lasers Surg Med; 2021 Jul; 53(5):647-653. PubMed ID: 33211334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of promestriene with vaginal fractional CO2 laser and radiofrequency treatments of genitourinary syndrome of menopause.
    Seganfredo IB; Bianchi C; Tacla M; Chedraui P; Haddad JM; Simoes R; Baracat EC; Soares JM
    Maturitas; 2024 Aug; 186():108008. PubMed ID: 38714422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Short-term efficacy of vaginal CO
    Kozma B; Póka R; Sipos A; Ács N; Takács P
    Orv Hetil; 2019 Oct; 160(41):1617-1622. PubMed ID: 31587579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design for fractional microablative CO
    Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
    Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapeutic option in genitourinary syndrome of menopause: pilot study using microablative fractional radiofrequency.
    Kamilos MF; Borrelli CL
    Einstein (Sao Paulo); 2017; 15(4):445-451. PubMed ID: 29364367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractional CO
    Murina F; Karram M; Salvatore S; Felice R
    J Sex Med; 2016 Dec; 13(12):1915-1917. PubMed ID: 27864031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Two Laser Treatment Strategies for Breast Cancer Survivors With Genitourinary Syndrome of Menopause.
    Okui N; Okui M; Kouno Y; Nakano K; Gambacciani M
    Cureus; 2023 May; 15(5):e38604. PubMed ID: 37284382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CO 2 laser, radiofrequency, and promestriene in the treatment of genitourinary syndrome of menopause in breast cancer survivors: a histomorphometric evaluation of the vulvar vestibule.
    Fernandes MFR; Bianchi-Ferraro AMHM; Sartori MGF; Jármy Di Bella ZIK; Cantarelli GC; Dedonatto C; Vanzin RB; Dardes RCM; Logullo ÂF; Patriarca MT;
    Menopause; 2023 Dec; 30(12):1213-1220. PubMed ID: 37963315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial.
    Paraiso MFR; Ferrando CA; Sokol ER; Rardin CR; Matthews CA; Karram MM; Iglesia CB
    Menopause; 2020 Jan; 27(1):50-56. PubMed ID: 31574047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of non-invasive vulvovaginal rejuvenation.
    Photiou L; Lin MJ; Dubin DP; Lenskaya V; Khorasani H
    J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):716-726. PubMed ID: 31714632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal laser therapy for GSM/VVA: where we stand now - a review by the EUGA Working Group on Laser.
    Salvatore S; Ruffolo AF; Phillips C; Athanasiou S; Cardozo L; Serati M;
    Climacteric; 2023 Aug; 26(4):336-352. PubMed ID: 37395104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microablative fractional CO
    Pitsouni E; Grigoriadis T; Tsiveleka A; Zacharakis D; Salvatore S; Athanasiou S
    Maturitas; 2016 Dec; 94():131-136. PubMed ID: 27823733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy of fractional CO
    Sindou-Faurie T; Louis-Vahdat C; Oueld Es Cheikh E; Canlorbe G; Mergui JL; Uzan C; Azaïs H
    Arch Gynecol Obstet; 2021 Apr; 303(4):955-963. PubMed ID: 33179118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. At-Home Transvaginal Device Following Fractional Carbon Dioxide Laser Treatment for Genitourinary Syndrome of Menopause.
    Alexiades M
    J Drugs Dermatol; 2020 Nov; 19(11):1076-1079. PubMed ID: 33196757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society.
    Portman DJ; Gass ML;
    Maturitas; 2014 Nov; 79(3):349-54. PubMed ID: 25179577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Double-Blind Randomized Sham-Controlled Trial to Evaluate the Efficacy of Fractional Carbon Dioxide Laser Therapy on Genitourinary Syndrome of Menopause.
    Cruff J; Khandwala S
    J Sex Med; 2021 Apr; 18(4):761-769. PubMed ID: 33757774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.